Nuvation Bio Inc.
NUVB
NYSE·Healthcare·Biotechnology·Mkt cap $2.4B
$6.81
▲ +0.59%
P/E
-15.67
Mkt Cap
$2.4B
52-Wk Range
$2.99–$9.75
52-Week Range
$2.99 - $9.75
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 95.1% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
1 reason
- High barriers to entry (70%+ gross margins)
Bear Case
1 risk
- Above-average volatility (beta 1.5).
Growth
Moderate growth ahead
Strong revenue growth (699% YoY)
Value
Trading at 0.0x Biotech & Therapeutics peers — a discount despite the growth profile.
Momentum
Hot
+41.9% over 3m
Quality
Excellent
High-growth business (500% revenue growth, 94% gross margin). Pre-profit but investing in growth.
Dividend
None
No dividend
Smart-money signal
Who's buying NUVB right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Recent earnings results
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 2, 2026
AUG 6, 2026
Reported EPS of -$0.15 vs -$0.14 consensus (-5.9% surprise). Revenue of $31.7M vs $27.0M expected (+17.2%).
EPS surprise · last 4Q
0 of 1 beats
Estimate
Actual
Q3 26
-5.9%
Revenue trend · last 8Q
—
—
—
+237%
+1705%
+633%
+2599%
+556%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$727.0K
$5.7M
$3.1M
$4.8M
$13.1M
$41.9M
$83.2M
$31.7M
Margins · last 8Q
Gross
97.1%
Operating
-161.1%
Profit
-198.3%
Wall Street consensus
6 analysts · 100% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
100%
Hold
0%
Sell
0%
Median Price Target
—
Latest: Cantor Fitzgerald · Aug 21, 2026
vs Industry
How NUVB stacks vs Biotechnology
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related